ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,067,000 | -63.6% | 798,873 | -77.3% | 0.37% | -58.1% |
| Q2 2019 | $41,405,000 | -4.8% | 3,517,856 | +10.4% | 0.87% | -15.0% |
| Q1 2019 | $43,488,000 | +50.5% | 3,185,983 | +13.0% | 1.03% | +49.6% |
| Q4 2018 | $28,892,000 | -9.4% | 2,818,788 | +47.2% | 0.69% | -4.7% |
| Q3 2018 | $31,879,000 | +23.4% | 1,914,690 | +17.1% | 0.72% | +19.4% |
| Q2 2018 | $25,834,000 | +261.3% | 1,635,035 | +190.4% | 0.60% | +284.7% |
| Q1 2018 | $7,151,000 | +89.8% | 563,037 | +210.8% | 0.16% | +80.5% |
| Q1 2017 | $3,768,000 | +0.6% | 181,143 | +0.6% | 0.09% | +2.4% |
| Q4 2016 | $3,744,000 | – | 180,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |